A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico.

Slides:



Advertisements
Similar presentations
Advances in shaking technologies Wolf Klöckner, Jochen Büchs Trends in Biotechnology Volume 30, Issue 6, Pages (June 2012) DOI: /j.tibtech
Advertisements

Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages (January 2012) DOI: /j.maturitas
The Survival Kit: Software to analyze survival data including possibly correlated random effects G. Mészáros, J. Sölkner, V. Ducrocq Computer Methods and.
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,
Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /
Influence of maternal nicotine exposure during gestation and lactation on lactate dehydrogenase isoenzyme profile and transcript levels in developing neonatal.
Eribulin—A review of preclinical and clinical studies
Gastric cancer Critical Reviews in Oncology / Hematology
Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi 
Exercise issues in older cancer survivors
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review  Cloé Brami, Ting Bao, Gary Deng  Critical.
Novel targets in gastric and esophageal cancer
Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell.
Critical Reviews in Oncology / Hematology
Nicoletta Colombo, Martin Gore 
Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions?  Séverine Guiu, Anita Wolfer, William Jacot, Pierre.
Volume 47, Issue 12, Pages (December 2011)
Philipp Dahm, Ari D. Silverstein, Alon Z
MITO (Multicentre Italian Trials in Ovarian cancer) - CERV2 trial: a randomized phase II study of carboplatin and paclitaxel +/- cetuximab, in advanced.
Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force  Silvio Monfardini,
Public health value of universal HPV vaccination
Critical Reviews in Oncology / Hematology
Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery  David Palma, Otto.
Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis 
The case for wider use of recombinant factor VIII concentrates
Critical Reviews in Oncology / Hematology
Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature  Omar Abdel-Rahman,
Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead  J. Carlijn Van Gaal, Eveline S.J.M. De Bont, Suzanne.
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey  Lazzaro Repetto  Critical.
Amy M. Lin, Charles J. Ryan, Eric J. Small 
Genistein: Its role in metabolic diseases and cancer
Jonathan P. Evans, Paul A. Sutton, Boleslaw K. Winiarski, Stephen W
Rituximab, fludarabine, and cyclophosphamide versus fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia: A systematic review.
Iron overload and chelation therapy in myelodysplastic syndromes
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)  Giorgio Arcangeli,
Volume 64, Pages e1-e3 (January 2017)
Abhimanyu Ghose, Ria Kundu, Tahir Latif 
Critical Reviews in Oncology / Hematology
Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment  Judith Maresch, Sebastian F. Schoppmann,
P. Therasse, S. Carbonnelle, J. Bogaerts 
Olfa Baroudi, Amel Benammar-elgaaied 
Clinically useful prognostic factors in acute myeloid leukemia
Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight  Giuseppe Aprile, Elena Ongaro, Marzia Del Re, Stefania.
Long non-coding RNA CASC2 in human cancer
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric.
Gwo Yaw Ho, Natasha Woodward, Jermaine I.G. Coward 
Critical Reviews in Oncology / Hematology
Primary renal carcinoid: Treatment and prognosis
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario  Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello  Critical.
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer  Miguel.
Gerhard J. Molderings  Critical Reviews in Oncology / Hematology 
Are patients willing to travel for better ovarian cancer care?
Stefania Turrina, Stefano Caratti, Domenico De Leo 
Gene therapy in haematology and oncology
Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2: The G-Step.
A Phase II Trial of Carboplatin and Weekly Topotecan in the First-Line Treatment of Patients with Extensive Stage Small Cell Lung Cancer  David R. Spigel,
Unknown ankylosing spondylitis with only cardiac involvement in patient with surgical indication: Call for patient and family members immunological screening 
Ovarian cancer screening: UKCTOCS trial – Authors' reply
R. George, S. Przybojewski, S. Theron  EJVES Extra 
Establishment of Italian national DNA database and the central laboratory: Some aspects  R. Biondo, F. De Stefano  Forensic Science International: Genetics.
K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani
Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)
I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M
Catherine J. Hunter, Isabelle G. De Plaen  Pathophysiology 
Volume 142, Issue 2, Pages (August 2016)
Analysis of forensic samples in Banco Nacional de Datos Genéticos
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Skin cancer epidemic in a wireless world
Increasing incidence of brain tumours in sparsely populated areas
Evaluation of the Differex™ System
Presentation transcript:

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico Breda, Giovanni Scambia, Carmela Pisano, Vittorina Zagonel, Domenica Lorusso, Stefano Greggi, Rocco De Vivo, Gabriella Ferrandina, Ciro Gallo, Francesco Perrone  Critical Reviews in Oncology / Hematology  Volume 66, Issue 3, Pages 229-236 (June 2008) DOI: 10.1016/j.critrevonc.2007.12.005 Copyright © 2008 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 Baseline geriatric evaluation. Critical Reviews in Oncology / Hematology 2008 66, 229-236DOI: (10.1016/j.critrevonc.2007.12.005) Copyright © 2008 Elsevier Ireland Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.